Literature DB >> 11727049

Bone density and 25-hydroxyvitamin D level in extrahepatic biliary atresia.

V Chongsrisawat1, P Ruttanamongkol, T Chaiwatanarat, B Chandrakamol, Y Poovorawan.   

Abstract

Biliary atresia (BA) represents a common cholestatic affliction of the gastrointestinal tract affecting infants and children. The objective of the present study was to evaluate 42 patients (20 with and 22 without jaundice) diagnosed with extrahepatic BA for bone mineral content and serum 25-hydroxyvitamin D (HVD) levels. Physical examination and anthropometric nutritional assessment were performed. The investigation included liver function tests and serum calcium (Ca), phosphate (P), magnesium (Mg), and 25-HVD levels. Dual-energy X-ray absorptiometry was used to measure the bone mineral density (BMD) of the lumbar spine (L(1)-L(4)). Our results showed that 16 jaundiced patients (80%) and only 3 nonjaundiced patients (13.6%) showed osteoporosis (P< 0.05). All patients had normal serum Ca and P levels. Only 1 nonjaundiced patient had a low serum Mg level. Serum 25-HVD levels (mean +/- SD) were 20.71 +/- 8.24, 16.12 +/- 4.3, and 9.18 +/- 5.84 ng/ml, respectively, in subjects with normal bone density (n=7), osteopenia (n=3), and osteoporosis (n=11). Bone disease represents a well-known complication among long-term survivors of BA. To date, the pathogenesis has remained unexplained. Since, as demonstrated in the present study, jaundiced patients develop osteoporosis more frequently than nonjaundiced patients, hyperbilirubinemia may have an influence. Bone-mineral deficiency can be detected earlier by means of BMD measurement (non-invasive method) than by measuring serum Ca, P, and Mg levels in these patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727049     DOI: 10.1007/s003830100003

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  9 in total

1.  Bone Density in Children With Chronic Liver Disease Correlates With Growth and Cholestasis.

Authors:  Kathleen M Loomes; Cathie Spino; Nathan P Goodrich; Thomas N Hangartner; Amanda E Marker; James E Heubi; Binita M Kamath; Benjamin L Shneider; Philip Rosenthal; Paula M Hertel; Saul J Karpen; Jean P Molleston; Karen F Murray; Kathleen B Schwarz; Robert H Squires; Jeffrey Teckman; Yumirle P Turmelle; Estella M Alonso; Averell H Sherker; John C Magee; Ronald J Sokol
Journal:  Hepatology       Date:  2018-12-27       Impact factor: 17.425

2.  Hepatic osteodystrophy complicated with bone fracture in early infants with biliary atresia.

Authors:  Tadao Okada; Shohei Honda; Hisayuki Miyagi; Masashi Minato; Akinobu Taketomi
Journal:  World J Hepatol       Date:  2012-10-27

3.  Efficacy of fat-soluble vitamin supplementation in infants with biliary atresia.

Authors:  Benjamin L Shneider; John C Magee; Jorge A Bezerra; Barbara Haber; Saul J Karpen; Trivellore Raghunathan; Philip Rosenthal; Kathleen Schwarz; Frederick J Suchy; Nanda Kerkar; Yumirle Turmelle; Peter F Whitington; Patricia R Robuck; Ronald J Sokol
Journal:  Pediatrics       Date:  2012-08-13       Impact factor: 7.124

Review 4.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

5.  Relationships between OPG, RANKL, bone metabolism, and bone mineral density in biliary atresia.

Authors:  Sittisak Honsawek; Tawatchai Chaiwatanarat; Paisarn Vejchapipat; Voranush Chongsrisawat; Nutchanart Thawornsuk; Yong Poovorawan
Journal:  Pediatr Surg Int       Date:  2009-01-29       Impact factor: 1.827

6.  Effect of liver transplantation on multiple bone fractures in an infant with end-stage biliary atresia: a case report.

Authors:  Shunsaku Katsura; Keiko Ogita; Tomoaki Taguchi; Sachiyo Suita; Tomoharu Yoshizumi; Yuji Soejima; Mitsuo Shimada; Yoshihiko Maehara
Journal:  Pediatr Surg Int       Date:  2005-01       Impact factor: 1.827

7.  Low bone mineral density and the severity of cholestasis in biliary atresia.

Authors:  Krittapak Homchan; Tawatchai Chaiwatanarat; Wanvisa Udomsinprasert; Voranush Chongsrisawat; Yong Poovorawan; Sittisak Honsawek
Journal:  World J Hepatol       Date:  2017-06-08

8.  Pamidronate decreases bilirubin-impaired cell death and improves dentinogenic dysfunction of stem cells from human deciduous teeth.

Authors:  Haruyoshi Yamaza; Soichiro Sonoda; Kazuaki Nonaka; Toshio Kukita; Takayoshi Yamaza
Journal:  Stem Cell Res Ther       Date:  2018-11-08       Impact factor: 6.832

9.  Bone health in a nonjaundiced population of children with biliary atresia.

Authors:  Rachel A Kramer; Babette S Zemel; Jessica L Arvay-Nezu; Virginia A Stallings; Mary B Leonard; Barbara A Haber
Journal:  Gastroenterol Res Pract       Date:  2009-07-05       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.